Journals / Okmeydanı Tıp Dergisi / 2017 / Cilt: 33 - Sayı: 2

Different Management Options for Tubo-Ovarian Abscess: A Tertiary Referral Center Experience

Tubo-Ovaryan Abselerde Farklı Yönetim Şekilleri: Üçüncü Basamak Hastane Deneyimi

Pages
87–92
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Correct decision will be helpful for patient reducing morbidity, adhesions, need for radical surgery and harmful to ovaries.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Tubo-ovarian abscess (TOA) is mostly a consequence of pelvic inflammatory disease (PID).
📊
Key Findings & Data:Material and Method: We examined 92 patients with TOA that had been hospitalized and treated medically or surgically. 53 patients had undergone operation and 39 patients had taken only antibiotherapy.
💡
Conclusion & Impact:Correct decision will be helpful for patient reducing morbidity, adhesions, need for radical surgery and harmful to ovaries.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Tubo-ovarian abscess (TOA) is mostly a consequence of pelvic inflammatory disease (PID). TOA is characterized by an inflammatory mass involving the fallopian tube, ovary and occasionally other adjacent pelvic organs. TOA is a serious life-threatening condition that must be diagnosed and managed immediately. Complete history and pelvic examination includes the most important part of the diagnosis. Surgery is necessary for both definitive diagnosis and treatment of TOA especially for suspicious abscess rupture or finding of a TOA in a postmenopausal woman. Our objective was to compare characteristics of patients who undergo surgical treatment and medical treatment. Material and Method: We examined 92 patients with TOA that had been hospitalized and treated medically or surgically. 53 patients had undergone operation and 39 patients had taken only antibiotherapy. Patients who underwent surgical treatment were called as Group 1 and took only medical treatment are called as Group 2.Results: When patients treated surgically are divided into 2 groups which were operated as salpengectomy/salpingooopherectomy and drainage, difference in mean values between these two groups were not observed except WBC count. When we compared mean values of patients between Group 1 and 2, parity, antibiotherapy duration and hospitalization period were found different.Conclusion: It's very important to decide that which patient should be hospitalized and treated with combination of surgical methods and antibiotherapy or which patient should take with only antibiotherapy. Correct decision will be helpful for patient reducing morbidity, adhesions, need for radical surgery and harmful to ovaries.

Özet

Amaç: Tubo-ovaryan abse çoğunlukla pelvik enflamatuvar hastalığın bir sonucudur. Tubo-ovaryan abse fallopian tüpleri, overleri ve sıklıkla diğer çevre pelvik organları da içeren inflamatuvar kitleyle karakterizedir. Tubo-ovaryan abse hızlıca tanı konulup yönetilmesi gereken ciddi yaşamı tehdit eden bir durumdur. Öykü ve pelvik muayene tanının en önemli kısmını oluşturur. Cerrahi hem kesin tanı hem de tedavide özellikle de şüpheli abse rüptüründe veya postmenopozal bir kadında tubo-ovaryan abse bulgusu mevcudiyetinde gereklidir. Amacımız cerrahi ve medikal tedavi alan hastaların karakteristik özelliklerini karşılaştırmaktı. Gereç ve Yöntem: Tubo-ovaryan abse tanısı olup, hospitalize edilen ve medikal veya cerrahi olarak tedavi edilmiş 92 hastayı inceledik. Elli üç hasta opere edilerek, 39 hasta ise yalnızca antibiyotik alarak tedavi edilmişti.Bulgular: Cerrahi ile tedavi olan hastalar Grup 1, yalnızca medikal tedavi alan hastalar ise Grup 2 olarak adlandırıldı. Bu iki grubun ortalama değerleri karşılaştırıldığında parite, antibiyotik ve hospitalizasyon süresi arasında farklılık bulundu. Sonuç: Hangi hastanın hospitalize edilip cerrahi ve medikal tedavi kombinasyonuyla tedavi edileceği, hangi hastanın yalnızca antibiyotik alması gerektiğinin kararı çok önemlidir. Doğru karar morbiditeyi, yapışıklığı, radikal cerrahi gereksinimini ve overlere hasarı azaltarak hasta için yararlı olacaktır.

🔖

Cite This Article

ÇELİKBGÖKSEVER, H., ÇELİK, E., YAŞA, C., YÜKSEL, S., ÇELİK, S., DURAL, Ö., ARK, H. C. (2017). Different Management Options for Tubo-Ovarian Abscess: A Tertiary Referral Center Experience. Okmeydanı Tıp Dergisi, Cilt: 33 - Sayı: 2, 87–92. https://ajindex.com/articles/340742

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Chappell CA, Wiesenfeld HC. Pathogenesis, diagnosis and management of severe pelvic inflammatory disease and tuboovarian abscess. Clin Obst Gynecol 2012;55(4):893-903.
  2. Schorge JO, Schaffer JI, Halvorson LM, Hoffman B, Bradshaw KD, Cunnıngham FG. Gynecologic Infections: In Williams Gynecology. 1st edition. McGrawHill, 2009:49-85
  3. Hajj SN, Mercer LJ, Ismail MA. Surgical approaches to pelvic infections in women. J Reprod Med 1988;33(1):159-63
  4. DeWitt J, Reining A, Allsworth JE, Peipert JF. Tuboovarian abscesses: Is size associated with duration of hospitalization and complications? Obst Gynecol Int 2010 Article ID 847041, 5 pages, 2010
  5. Wiesenfeld HC, Sweet RL. Progress in the management of tuboovarian abscesses. Clin Obst Gynecol 1993;36(2):433-44.
  6. Burkman RT. Intrauterine devices and pelvic inflammatory disease: evolving perspectives on the data. Obstet Gynecol Surv 1996;51:35.
  7. Landers DV, Sweet RL. Current trends in the diagnosis and treatment of tuboovarian abscess. Am J Obst Gynecol 1985;151(8):1098-110.
  8. Soper DE. Pelvic inflammatory disease. Obstet Gynecol 2010;116(2):419-28.
  9. Halperin R, Svirsky R, Vaknin Z, Ben-Ami I, Schneider D, Pansky M. Predictors of tuboovarian abscess in acute pelvic inflammatory disease. J Reprod Med 2008;53(1):40-4
  10. Mercer LJ, Hajj SN, Ismail MA, Block BS. Use of C-reactive protein to predict the outcome of medical management of tuboovarian abscesses. J Reprod Med 1988;33(1):164-7
  11. Gjelland K, Ekerhovd E, Granberg S. Transvaginal ultrasound-guided aspiration for treatment of tuboovarian abscess: a study of 302 cases. Am J Obstet Gynecol 2005;193:1323-30.
  12. Paik CK, Waetjen E, Xing G, Dai J, Sweet RL. Hospitalizations for pelvic inflammatory disease and tuboovarian abscess. Obstet Gynecol 2006;107(3):611-6.
  13. Hurt KJ, Duile MW, Bienstock JL, Fox HE, Wallach EE. Infections of the genital tract. In: The Johns Hopkins Manual of Gynecology and Obstetrics. 4th edition. 2011:322-40
  14. Reed SD, Landers DV, Sweet RL. Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum beta-lactam agents versus clindamycin-containing regimens. Am J Obstet Gynecol 1991;164